Advocacy & Coverage Issues

ACCC Advocacy

View advocacy efforts by the Association of Community Cancer Centers (ACCC) on coverage and payment issues here.

Hazardous Drug Safe Handling

In March 2014, the US Pharmacopeial Convention (USP) proposed new USP General Chapter <800> “Hazardous Drugs—Handling in Healthcare Settings.” In response to numerous stakeholder comments, a revised draft Chapter <800> was published in December 2014. While OPEN supports USP’s dedication to ensuring the highest standards for personnel safety, many guidelines set forth in Chapter <800> would be unduly burdensome and could cause some facilities to discontinue compounding drugs for their patients. Our comment letters encourage USP to reconsider these guidelines. For further details, read our ACCCBuzz blog post.

340B Drug Pricing Program

Off-Label Coverage Issues

The Medicare statute requires carriers to cover off-label uses of cancer therapies when such uses are supported by citations in certain compendia or by clinical evidence in peer-reviewed literature.

ACCC Position Statements

Access additional ACCC Position Statements, Advocacy Letters, and Comment Letters here.

ACCC Advocacy Issues

ACCC has identifed critical issues that may impact the delivery of quality care in 2015 and beyond:

Connect with the ACCC Legislative Action Center here.


Email Sign Up